Alzheimer's disease (AD) is the most common form of dementia worldwide. β-amyloid
peptide (Aβ) is currently assumed to be the main cause of synaptic dysfunction and cognitive …

Objective: Public health campaigns encouraging early help seeking have increased rates of
mild cognitive impairment (MCI) diagnosis in Western countries, but we know little about …

Background Because anxiety is postulated as a risk factor for dementia, we performed a
systematic review and meta-analysis to investigate whether anxiety predicts cognitive …

The concept of mild cognitive impairment (MCI) as an intermediate state between normal
cognition and dementia entered into the vernacular of geriatric medicine more than 30 years …

Reasons for the Study: The Neuropsychiatric Inventory (NPI) has been used for studies of
neuropsychiatric symptoms in neurodegenerative disorders for the past 25 years. This article …

Clinical and epidemiologic research has focused on the identification of risk factors that may
be modified in predementia syndromes, at a preclinical and early clinical stage of dementing …

Objectives Individuals with mild cognitive impairment (MCI) are at high risk of developing
dementia and/or Alzheimer disease (AD). Among persons with MCI, depression and anxiety …

Background: Neuropsychiatric symptoms (NPS) in dementia have received much attention
due to their high prevalence and their significant implications. NPS in mild cognitive …

Alzheimer's disease (AD) is a complex progressive brain degenerative disorder that has
effects on multiple cerebral systems. In addition to cognitive and functional decline, diverse …

Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state
between normal aging and dementia. This condition has multiple heterogeneous sources …